{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T17:19:17Z","timestamp":1758820757723},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1983,1,1]],"date-time":"1983-01-01T00:00:00Z","timestamp":410227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[1983,1]]},"DOI":"10.1007\/bf00919134","type":"journal-article","created":{"date-parts":[[2005,1,2]],"date-time":"2005-01-02T07:43:12Z","timestamp":1104651792000},"page":"14-21","source":"Crossref","is-referenced-by-count":6,"title":["Serum interferon in Navajo children with severe combined immunodeficiency disease inhibits lymphoblastogenesis"],"prefix":"10.1007","volume":"3","author":[{"given":"James F.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda M.","family":"Minnich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David O.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. A.","family":"Fulginiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zita","family":"Ingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlyn P.","family":"Langford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. John","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.4049\/jimmunol.121.5.1726","volume":"121","author":"DA Carson","year":"1978","unstructured":"Carson DA, Kay J, Seegmiller JE: Differential sensitivity of human leukemic T-cell lines and B-cell lines to growth inhibition by deoxyadenosine. J Immunol 121:1726?1731, 1978","journal-title":"J Immunol"},{"key":"CR2","first-page":"7","volume-title":"Birth Defects Original Article Series IV: Immunologic Deficiency Diseases in Man","author":"MD Cooper","year":"1968","unstructured":"Cooper MD, Perey DY, Peterson RDA, Gabrielson AE, Good RA: The two component concept of the immune system.In Birth Defects Original Article Series IV: Immunologic Deficiency Diseases in Man, D Bergsma (ed.). New York, The National Foundation, 1968, pp 7?16"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM197508282930904","volume":"293","author":"KW Pyke","year":"1975","unstructured":"Pyke KW, Dosch HM, Ipp MM, Gelfand EW: Demonstration of an intrathymic defect in a case of severe combined immunodeficiency disease. N Engl J Med 293:424?428, 1975","journal-title":"N Engl J Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJM197402072900608","volume":"290","author":"T Merigan","year":"1974","unstructured":"Merigan T: Host defenses against viral disease. N Engl J Med 290:323?329, 1974","journal-title":"N Engl J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0090-1229(80)90115-4","volume":"17","author":"JF Jones","year":"1980","unstructured":"Jones JF, Sieber OF Jr, Fulginiti VA, Ochs H, Schulte-Wisserman H, Hong R: Predominance of B-lymphocyte function after culture thymus fragment therapy in severe combined immunodeficiency disease. Clin Immunol Immunopathol 17:439?450, 1980","journal-title":"Clin Immunol Immunopathol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/blood.V50.1.55.55","volume":"50","author":"C Payne","year":"1977","unstructured":"Payne C, Jones JF, Sieber OF Jr, Fulginiti VA: Parallel tubular arrays in severe combined immunodeficiency disease: An ultrastructural study of peripheral blood lymphocytes. Blood 50:55?64, 1977","journal-title":"Blood"},{"key":"CR7","doi-asserted-by":"crossref","unstructured":"Sieber O, Fulginiti VA, Durie B, Salmon S: Successful immunological reconstitution in severe combined immunodeficiency disease with transplantation from a non-compatible donor. Clin Res 22:230A, 1974","DOI":"10.1203\/00006450-197404000-00472"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/archpedi.1972.02110080089005","volume":"123","author":"SE Salmon","year":"1972","unstructured":"Salmon SE, Mogerman SN, Perkins HA, Smith B, Lehrer RI, Shinefield HR: Transplantation of treated lymphocytes in lymphopenic immunologic deficiency. Am J Dis Child 123:111?115, 1972","journal-title":"Am J Dis Child"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0140-6736(80)91833-4","volume":"2","author":"S Murphy","year":"1980","unstructured":"Murphy S, Hayward A, Troup G, Devor EF, Coons T: Gene enrichment in an American Indian population: An examination of severe combined immunodeficiency disease. Lancet 2:502?505, 1980","journal-title":"Lancet"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.4049\/jimmunol.126.4.1620","volume":"126","author":"MP Langford","year":"1981","unstructured":"Langford MP, Weigent DA, Georgiades JA, Johnson HM, Stanton GJ: Antibody to staphylococcal enterotoxin A-induced human interferon (IFN?). J Immunol 126:1620?1623, 1981","journal-title":"J Immunol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4049\/jimmunol.115.1.230","volume":"115","author":"MJ Valle","year":"1975","unstructured":"Valle MJ, Jordon GW, Haahr S, Merigan TS: Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons. J Immunol 115:230?233, 1975","journal-title":"J Immunol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/IAI.22.1.62-68.1978","volume":"22","author":"MP Langford","year":"1978","unstructured":"Langford MP, Stanton GJ, Johnson HM: Biological effects of staphylococcal enterotoxin A on human peripheral blood lymphocytes. Infect Immun 22:62?68, 1978","journal-title":"Infect Immun"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-3083.1974.tb01305.x","volume":"3","author":"H Blomgren","year":"1974","unstructured":"Blomgren H, Strander H, Cantell K: Effect of human leukocyte interferon on the response of lymphocytes to mitogenic stimuli in vitro. Scand J Immunol 3:697?705, 1974","journal-title":"Scand J Immunol"},{"key":"CR14","first-page":"219","volume-title":"Regulatory mechanisms in lymphocyte activation","author":"TB Tomasi Jr","year":"1968","unstructured":"Tomasi TB Jr: Serum factors which suppress the immune response.In Regulatory mechanisms in lymphocyte activation, DO Lucas (ed). New York, Academic Press, 1968, pp 219?248"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0162-3109(80)90056-9","volume":"2","author":"RS Krakauer","year":"1980","unstructured":"Krakauer RS, Clough JD: Suppressor factors: Potential for immune therapy. Immunopharmacology 2:271?284, 1980","journal-title":"Immunopharmacology"},{"key":"CR16","volume-title":"Research Reference Reagent Note No. 22","author":"Research Resources Branch","year":"1981","unstructured":"Research Resources Branch: Research Reference Reagent Note No. 22. Bethesda, MD: National Institute of Allergy and Infectious Diseases, 1981"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000232619","volume":"63","author":"S Einhorn","year":"1980","unstructured":"Einhorn S, Blomgren H, Strander H: Effect of an intramuscular injection of human leukocyte interferon on blood leukocyte counts and proportions of lymphocytes forming E, EA and EAC rosettes. Int Arch Allergy Appl Immunol 63:139?144, 1980","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"CR18","first-page":"13","volume-title":"Interferon 2","author":"J Taylor-Papadimitriou","year":"1980","unstructured":"Taylor-Papadimitriou J: Effects of interferons on cell growth and function.In Interferon 2, I Gresser (ed). London, Academic Press, 1980, pp 13?46"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1980.tb20601.x","volume":"350","author":"E DeMaeyer","year":"1980","unstructured":"DeMaeyer E, Maeyer-Guignard JD: Immunoregulatory action of type I interferon in the mouse. Ann NY Acad Sci 350:1?11, 1980","journal-title":"Ann NY Acad Sci"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7326\/0003-4819-93-3-399","volume":"93","author":"JU Gutterman","year":"1980","unstructured":"Gutterman JU, Blumenschein GR, Alexanian R, Yap Hy, Buzdar AU, Cabanillas F, Hortobagyi GN, Hersh EM, Rasmussen SL, Harmon M, Kramer M, Pestka S: Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma and indignant lymphoma. Ann Intern Med 93:399?406, 1980","journal-title":"Ann Intern Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/jir.1980.1.101","volume":"1","author":"L Rasmussen","year":"1980","unstructured":"Rasmussen L, Merigan TC: Effect of interferon therapy on circulating lymphocytes in humans. J Interferon Res 1:101?110, 1980","journal-title":"J Interferon Res"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0022-3476(67)80324-X","volume":"70","author":"ME Miller","year":"1967","unstructured":"Miller ME, Hummeler K: Thymic dysplasia (?Swiss agammaglobulinemia?). II. Morphologic and functional observations. J Pediat 70:737?744, 1967","journal-title":"J Pediat"},{"key":"CR23","first-page":"312","volume":"1","author":"CG Ray","year":"1970","unstructured":"Ray CG, Davis S: Leukocyte interferon production in immunodeficiency diseases. Lancet 1:312, 1970","journal-title":"Lancet"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4049\/jimmunol.112.2.617","volume":"112","author":"LB Epstein","year":"1974","unstructured":"Epstein LB, Ammann AJ: Evaluation of T-lymphocyte effector function in immunodeficiency disease: Abnormality in mitogen-stimulated interferon in patients with selective IgA deficiency. J Immunol 112:617?626, 1974","journal-title":"J Immunol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1749-6632.1980.tb20670.x","volume":"350","author":"\u00d6 Stranneg\u00e5rd","year":"1980","unstructured":"Stranneg\u00e5rd \u00d6, Bj\u00f6rkander J, Hermodsson S, Lundgren E, Stranneg\u00e5rd, IL, Westberg G: Interferon in immunodeficient patients. Ann NY Acad Sci 350:589?590, 1980","journal-title":"Ann NY Acad Sci"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/B978-0-12-178250-4.50022-2","volume-title":"Biology of the Lymphokines","author":"LB Epstein","year":"1979","unstructured":"Epstein LB: The comparative biology of immune and classical interferons.In Biology of the Lymphokines, S Cohen, E Pick, JJ Oppenheim (eds), New York, Academic Press, 1979, pp 443?514"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF00922762","volume":"1","author":"L Epstein","year":"1981","unstructured":"Epstein L, Gupta S: Human T-lymphocytes: Subset production of immune (?) interferon. J Clin Immunol 1:186?194, 1981","journal-title":"J Clin Immunol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM197907053010102","volume":"301","author":"JJ Hooks","year":"1979","unstructured":"Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL: Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 301:5?8, 1979","journal-title":"N Engl J Med"},{"key":"CR29","first-page":"579","volume-title":"Interferon: Properties and Clinical Uses","author":"T Hahn","year":"1980","unstructured":"Hahn T, Levin S: Interferon system assay in children.In Interferon: Properties and Clinical Uses, A Khan, NO Hill, GL Dorn (eds). Dallas, Leland Fikes, 1980, pp 579?588"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/268067a0","volume":"268","author":"TC Merigan","year":"1977","unstructured":"Merigan TC, Oldstone MBA, Welsh RM: Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice. Nature 268:67?68, 1977","journal-title":"Nature"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.1980.tb20602.x","volume":"350","author":"I Gresser","year":"1980","unstructured":"Gresser I, Morel-Maroger L, Rivi\u00e8re Y, Guillon J-C, Tovey MG: Interferon-induced disease in mice and rats. Ann NY Acad Sci 350:12?20, 1980","journal-title":"Ann NY Acad Sci"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00919134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00919134\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00919134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T10:06:19Z","timestamp":1682935579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00919134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1983,1]]}},"alternative-id":["BF00919134"],"URL":"https:\/\/doi.org\/10.1007\/bf00919134","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,1]]}}}